Moreover, in a recent work, Kim and colleagues demonstrated that in a panel of CCA cell lines, GEM resistance was associated to high levels of simultaneous expression of both APEX1 and Jagged 1 proteins, suggesting these molecules are potential therapeutic targets for CCA chemoresistance [45]. The gene discussed is JAG1; the disease is cholangiocarcinoma.